Cited by 1,301Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

Open access

Hong, Hyenjong, Takahashi, Kazutoshi, Ichisaka, Tomoko, Aoi, Takashi, Kanagawa, Osami, Nakagawa, Masato, Okita, Keisuke, Yamanaka, Shinya·2009·Nature

DOI 10.1038/nature08235PMC PMC2917235

Open this paper in CoChat — free account

Abstract

Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08235

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citation
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citation
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citation
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citation
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citation
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660

Flagged first, then by citations

Show all 23 references

Sorted by citations

Items 401–500 of 1,003

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells
Li, J., Song, W., Pan, G., & Zhou, J. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0050-z · Cited by 55
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal
Chandrakesan, P., May, R. J., Qu, D., Weygant, N., Taylor, V. E., Li, J. D., Ali, N., Sureban, S. M., Qante, M., Wang, T. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5129 · Cited by 50
Translating Induced Pluripotent Stem Cells from Bench to Bedside: Application to Retinal Diseases
Barnea-Cramer, A. O., & MacLaren, R. E. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020008 · Cited by 50
SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53
Lynch, C. J., Shah, Z. H., Allison, S. J., Ahmed, S. U., Ford, J. R., Warnock, L. J., Li, H., Serrano, M., & Milner, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013502 · Cited by 51
A Stochastic Model of Epigenetic Dynamics in Somatic Cell Reprogramming
Flöttmann, M., Scharp, T., & Klipp, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00216 · Cited by 50
Epigenetic Regulation of Pluripotent Genes Mediates Stem Cell Features in Human Hepatocellular Carcinoma and Cancer Cell Lines
Wang, X. Q., Ng, R. K., Ming, X., Zhang, W., Chen, L., Chu, A. C. Y., Pang, R. W. C., Lo, C. M., Tsao, S. W., Liu, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072435 · Cited by 50
Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells
Hosain, S. B., Khiste, S., Uddin, M. B., Vorubindi, V., Ingram, C., Zhang, S., Hill, R. A., Gu, X., & Liu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11169 · Cited by 53
TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
George, B., Kantarjian, H. M., Baran, N., Krocker, J. D., & Rios, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910782 · Cited by 53
Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells
Motohara, T., Masuko, S., Ishimoto, T., Yae, T., Onishi, N., Muraguchi, T., Hirao, A., Matsuzaki, Y., Tashiro, H., Katabuchi, H., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr183 · Cited by 50
The Role of the p53 Protein in Stem-Cell Biology and Epigenetic RegulationPreprint
Levine, A. J., Puzio‐Kuter, A. M., Chan, C. S., & Hainaut, P. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026153 · Cited by 53
Cellular senescence and senescence-associated secretory phenotype: comparison of idiopathic pulmonary fibrosis, connective tissue disease-associated interstitial lung disease, and chronic obstructive pulmonary disease
Okuda, R., Aoshiba, K., Matsushima, H., Ogura, T., Okudela, K., & Ohashi, K. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.11 · Cited by 49
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression
Zhou, Y., Nakajima, R., Shirasawa, M., Fikriyanti, M., Zhao, L., Iwanaga, R., Bradford, A. P., Kurayoshi, K., Araki, K., & Ohtani, K. (2023) · Biology · doi:10.3390/biology12121511 · Cited by 52
Reversal of Aberrant Cancer Methylome and Transcriptome upon Direct Reprogramming of Lung Cancer Cells
Mahalingam, D., Kong, C. M., Lai, J. K. H., Tay, L. L., Yang, H. H., & Wang, X. (2012) · Scientific Reports · doi:10.1038/srep00592 · Cited by 50
Pluripotent Stem Cell–Derived Hepatocytes: Potential and Challenges in Pharmacology
Szkolnicka, D., Zhou, W., Lucendo‐Villarin, B., & Hay, D. C. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140306 · Cited by 51
A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells
Han, J., Sachdev, P. S., & Sidhu, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012297 · Cited by 49
Cell surface GRP78 promotes stemness in normal and neoplastic cells
Conner, C., Lager, T. W., Guldner, I. H., Wu, M.-Z., Hishida, Y., Hishida, T., Ruiz, S., Yamasaki, A. E., Gilson, R. C., Belmonte, J. C. I., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60269-y · Cited by 49
Accelerating progress in induced pluripotent stem cell research for neurological diseases
Ito, D., Okano, H., & Suzuki, N. (2012) · Annals of Neurology · doi:10.1002/ana.23596 · Cited by 49
Generation of induced pluripotent stem cells using site-specific integration with phage integrase
Ye, L., Chang, J. C., Lin, C., Qi, Z.-X., Yu, J.-W., & Kan, Y. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1012677107 · Cited by 51
Advanced Feeder-Free Generation of Induced Pluripotent Stem Cells Directly From Blood Cells
Trokovic, R., Weltner, J., Nishimura, K., Ohtaka, M., Nakanishi, M., Salomaa, V. V., Jalanko, A., Otonkoski, T., & Kyttälä, A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0113 · Cited by 48
JMJD5 Regulates Cell Cycle and Pluripotency in Human Embryonic Stem Cells
Zhu, H., Hu, S., & Baker, J. C. (2014) · Stem Cells · doi:10.1002/stem.1724 · Cited by 49
The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation
Kwon, D., Kim, J., Cha, B.-H., Park, K., Han, I., Park, K., Bae, H., Han, M., Kim, K., & Lee, S. (2016) · Cell Transplantation · doi:10.3727/096368915x689703 · Cited by 51
iPSCs: On the Road to Reprogramming Aging
Soria‐Valles, C., & López-Otı́n, C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.010 · Cited by 49
SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer
Schaefer, T., Steiner, R., & Lengerke, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144902 · Cited by 51
Trp53 negatively regulates autoimmunity via the STAT3‐Th17 axis
Zhang, S., Zheng, M., Kibe, R., Huang, Y., Marrero, L., Warren, S., Zieske, A. W., Iwakuma, T., Kolls, J. K., & Cui, Y. R. (2011) · The FASEB Journal · doi:10.1096/fj.10-175299 · Cited by 48
Cells, Stem Cells, and Cancer Stem Cells
Aguilar-Gallardo, C., & Simón, C. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1331792 · Cited by 48
Visualizing Structure and Transitions for Biological Data ExplorationPreprint
Moon, K. R., van Dijk, D., Wang, Z., Gigante, S., Burkhardt, D. B., Chen, W. S., Yim, K., van den Elzen, A. M. G., Hirn, M. J., Coifman, R. R., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/120378 · Cited by 56
Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood–Derived Cells
Damien, P., & Allan, D. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.05.022 · Cited by 47
Fetal environment, epigenetics, and pediatric renal disease
Woroniecki, R. P., Gaikwad, A. B., & Suszták, K. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1714-8 · Cited by 48
New Simple and Rapid Method for Purification of Mesenchymal Stem Cells from the Human Umbilical Cord Wharton Jelly
Montanucci, P., Basta, G., Pescara, T., Pennoni, I., Giovanni, F. D., & Calafiore, R. (2011) · Tissue Engineering. Part A · doi:10.1089/ten.tea.2010.0587 · Cited by 50
SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of “cancer cells with neural stemness” in a p53-dependent manner
Lee, J., Park, J., Kwon, O., Lee, T.-H., Nakano, I., Miyoshi, H., Chun, K., Park, M., Lee, H. J., Kim, S. U., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou145 · Cited by 47
GLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenance
Scoville, D. W., Kang, H. S., & Jetten, A. M. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.09.01 · Cited by 47
Concise Review: Generation of Neurons From Somatic Cells of Healthy Individuals and Neurological Patients Through Induced Pluripotency or Direct Conversion
Velasco, I., Salazar, P., Giorgetti, A., Ramos–Mejía, V., Castaño, J., Romero–Moya, D., & Menéndez, P. R. (2014) · Stem Cells · doi:10.1002/stem.1782 · Cited by 49
Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells
Kinoshita, T., Nagamatsu, G., Kosaka, T., Takubo, K., Hotta, A., Ellis, J., & Suda, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.013 · Cited by 46
IGF-1 prevents oxidative stress induced-apoptosis in induced pluripotent stem cells which is mediated by microRNA-1
Li, Y., Shelat, H. S., & Geng, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.139 · Cited by 46
Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells
Liu, Y.-J., Cheng, H., Gao, S., Lu, X., He, F., Hu, L., Hou, D., Zou, Z., Li, Y., Zhang, H., et al. (2013) · Leukemia · doi:10.1038/leu.2013.304 · Cited by 50
Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma
Davis, L. E., Nusser, K. D., Przybył, J., Pittsenbarger, J., Hofmann, N. E., Varma, S., Vennam, S., Dêbiec‐Rychter, M., van de Rijn, M., & Davare, M. A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1075 · Cited by 46
Oct4 Interaction with Hmgb2 Regulates Akt Signaling and Pluripotency
Campbell, P. A., & Rudnicki, M. A. (2013) · Stem Cells · doi:10.1002/stem.1365 · Cited by 46
Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts
Capetian, P., Azmitia, L. M., Pauly, M. G., Krajka, V., Stengel, F. C., Bernhardi, E.-M., Klett, M., Meier, B., Seibler, P., Stanslowsky, N., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00245 · Cited by 45
Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size
Sui, L., Xin, Y., Du, Q., Georgieva, D., Diedenhofen, G., Haataja, L., Su, Q., Zuccaro, M. V., Kim, J., Fu, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.141553 · Cited by 47
Survival signaling in the preimplantation embryo
O’Neill, C., Li, Y., & Jin, X. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2011.12.016 · Cited by 45
Pluripotent stem cells and gene therapy
Šimara, P., Motl, J. A., & Kaufman, D. S. (2013) · Translational research · doi:10.1016/j.trsl.2013.01.001 · Cited by 49
Concise Review: Managing Genotoxicity in the Therapeutic Modification of Stem Cells
Baum, C., Modlich, U., Göhring, G., & Schlegelberger, B. (2011) · Stem Cells · doi:10.1002/stem.716 · Cited by 44
Dedifferentiation of Human Terminally Differentiating Keratinocytes into Their Precursor Cells Induced by Basic Fibroblast Growth Factor
Sun, X., Fu, X., Han, W., Zhao, Y., Liu, H., & Sheng, Z. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1037 · Cited by 45
Lentivirus-mediated Reprogramming of Somatic Cells in the Absence of Transgenic Transcription Factors
Kane, N. M., Nowrouzi, A., Mukherjee, S., Blundell, M. P., Greig, J. A., Lee, W. K., Houslay, M. D., Milligan, G., Mountford, J. C., Kalle, C. V., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.231 · Cited by 44
Lysine methylation represses p53 activity in teratocarcinoma cancer cells
Zhu, J., Dou, Z., Sammons, M. A., Levine, A. J., & Berger, S. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610387113 · Cited by 44
Mdm2 as a chromatin modifier
Wienken, M., Moll, U. M., & Dobbelstein, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw046 · Cited by 44
p53 switches off pluripotency on differentiation
Lin, T., & Lin, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0498-1 · Cited by 44
Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis
Papa, L., Djedaini, M., & Hoffman, R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14133 · Cited by 47
Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism
Liu, J., Brzeszczyńska, J., Samuel, K., Black, J., Palakkan, A. A., Anderson, R. A., Gallagher, R., & Ross, J. A. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.08.004 · Cited by 43
Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine
Anastasia, L., Pelissero, G., Venerando, B., & Tettamanti, G. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.14 · Cited by 44
Melatonin improves reprogramming efficiency and proliferation of bovine‐induced pluripotent stem cells
Bai, C., Li, X., Gao, Y., Yuan, Z., Hu, P., Wang, H., Liu, C., Guan, W., & Ma, Y. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12334 · Cited by 43
A novel machine learning based approach for iPS progenitor cell identification
Zhang, H., Shao, X., Peng, Y., Teng, Y., Saravanan, K. M., Zhang, H., Li, H., & Wei, Y. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007351 · Cited by 43
Tp53 Suppression Promotes Cardiomyocyte Proliferation during Zebrafish Heart Regeneration
Shoffner, A. R., Cigliola, V., Lee, N., Ou, J., & Poss, K. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108089 · Cited by 46
5-Aminoimidazole-4-carboxyamide Ribonucleoside Induces G1/S Arrest and Nanog Downregulation via p53 and Enhances Erythroid Differentiation
Chae, H., Lee, M. R., & Broxmeyer, H. E. (2011) · Stem Cells · doi:10.1002/stem.778 · Cited by 43
Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family
Soyombo, A. A., Wu, Y., Kolski, L., Rios, J. J., Rakheja, D., Chen, A. P., Kehler, J., Hampel, H., Coughran, A. J., & Ross, T. S. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.004 · Cited by 49
Retraction Note: Stimulus-triggered fate conversion of somatic cells into pluripotency
Obokata, H., Wakayama, T., Sasai, Y., Kojima, K., Vacanti, M. P., Niwa, H., Yamato, M., & Vacanti, C. A. (2014) · Nature · doi:10.1038/nature13598 · Cited by 43
Retracted
Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease
Tuijn, C. F. J. V., van Beers, E. J., Schnog, J. B., & Biemond, B. J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21731 · Cited by 42
A Novel Small Molecule Facilitates the Reprogramming of Human Somatic Cells into a Pluripotent State and Supports the Maintenance of an Undifferentiated State of Human Pluripotent Stem Cells
Lee, J., Xia, Y., Son, M., Jin, G., Seol, B., Kim, M., Son, M. J., Do, M., Lee, M., Kim, D., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206691 · Cited by 42
Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming
Ruetz, T. J., Pfisterer, U., Stefano, B. D., Ashmore, J., Beniazza, M., Tian, T. V., Kaemena, D. F., Tosti, L., Tan, W. S., Manning, J. R., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.013 · Cited by 43
Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
Papa, L., Zimran, E., Djedaini, M., Ge, Y., Özbek, U., Sebra, R., Sealfon, S. C., & Hoffman, R. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024273 · Cited by 43
RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
Garancher, A., Suzuki, H., Haricharan, S., Chau, L. Q., Masihi, M. B., Rusert, J. M., Norris, P. S., Carrette, F., Romero, M. M., Morrissy, A. S., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0628-4 · Cited by 42
Retracted
Epigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 43
Telomeres And Telomerase in Adult Stem Cells and Pluripotent Embryonic Stem Cells
Marión, R. M., & Blasco, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_9 · Cited by 46
Global DNA Hypomethylation Prevents Consolidation of Differentiation Programs and Allows Reversion to the Embryonic Stem Cell State
Schmidt, C. S., Bultmann, S., Meilinger, D., Zacher, B., Tresch, A., Maier, K. C., Peter, C., Martin, D. E., Leonhardt, H., & Spada, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052629 · Cited by 44
Derivation of Induced Pluripotent Stem Cells from Human Peripheral Circulating T Cells
Seki, T., Yuasa, S., & Fukuda, K. (2011) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc04a03s18 · Cited by 41
Regulation of Stem Cell Plasticity: Mechanisms and Relevance to Tissue Biology and Cancer
Strauss, R., Hamerlik, P., Lieber, A., & Bartek, J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.2 · Cited by 41
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Durnaoglu, S., Genç, Ş., & Genç, K. (2011) · Stem Cells International · doi:10.4061/2011/212487 · Cited by 44
Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability
Fukawatase, Y., Toyoda, M., Okamura, K., Nakamura, K.-I., Nakabayashi, K., Takada, S., Yamazaki‐Inoue, M., Masuda, A., Nasu, M., Hata, K., et al. (2014) · Scientific Reports · doi:10.1038/srep05421 · Cited by 41
The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk
Kumar, K. K., Aboud, A. A., & Bowman, A. B. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.005 · Cited by 42
Physiological cellular reprogramming and cancer
Abollo‐Jiménez, F., Jiménez, R., & Cobaleda, C. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.002 · Cited by 42
iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery
Zhang, R., Zhang, L., & Xie, X. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.21 · Cited by 42
Biological Significance of the Suppression of Oxidative Phosphorylation in Induced Pluripotent Stem Cells
Zhang, C., Skamagki, M., Liu, Z., Ananthanarayanan, A., Zhao, R., Li, H., & Kim, K. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.098 · Cited by 41
Stem cells and regenerative medicine for neural repair
Takahashi, J. B. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.03.006 · Cited by 43
Advances in Gene Therapy for Fanconi Anemia
Rı́o, P., Navarro, S., & Bueren, J. A. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.124 · Cited by 41
Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
Araki, R., Hoki, Y., Suga, T., Obara, C., Sunayama, M., Imadome, K., Fujita, M., Kamimura, S., Nakamura, M., Wakayama, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13830-x · Cited by 42
METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4
Zang, Y., Tian, Z., Wang, D., Li, Y., Zhang, W., Ma, C., Liao, Z., Gao, W., Qian, L., Xu, X., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03085-2 · Cited by 40
Therapeutic targeting of the p53 pathway in cancer stem cells
Prabhu, V. V., Allen, J. E., Hong, B., Zhang, S., Cheng, H., & El‐Deiry, W. S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.726985 · Cited by 40
Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma
Cheng, Y., Cheung, A. K. L., Ko, J. M. Y., Phoon, Y. P., Chiu, P. M., Lo, P. H. Y., Waterman, M. L., & Lung, M. L. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-44 · Cited by 42
Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells.
Wada, H., Kojo, S., Kusama, C., Okamoto, N., Sato, Y., Ishizuka, B., & Seino, K. (2011) · International Immunology · doi:10.1093/intimm/dxq458 · Cited by 42
Genomic instability during reprogramming by nuclear transfer is DNA replication dependent
Chia, G., Agudo, J., Treff, N. R., Sauer, M. V., Billing, D. L., Brown, B. D., Baer, R. J., & Egli, D. M. (2017) · Nature Cell Biology · doi:10.1038/ncb3485 · Cited by 40
Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes
Loeken, M. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01338-4 · Cited by 43
Loss of a single allele for Ku80 leads to progenitor dysfunction and accelerated aging in skeletal muscle
Didier, N., Hourdé, C., Amthor, H., Marazzi, G., & Sassoon, D. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101075 · Cited by 43
Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming
Han, J. W., & Yoon, Y. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3814 · Cited by 43
Pluripotent Reprogramming of Fibroblasts by Lentiviralmediated Insertion of SOX2, C-MYC, and TCL-1A
Picanço‐Castro, V., Russo, E. M. D. S., Reis, L. C. J., Fraga, A. M., Magalhães, D. A., Orellana, M. D., Panepucci, R. A., Pereira, L. V., & Covas, D. T. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0424 · Cited by 44
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice
Leonova, K. I., Shneyder, J., Antoch, M. P., Toshkov, I. A., Novototskaya, L. R., Komarov, P. G., Komarova, E. A., & Gudkov, A. V. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11508 · Cited by 40
Inducible pluripotent stem cells: not quite ready for prime time?
Robbins, R. D., Prasain, N., Maier, B. F., Yöder, M. C., & Mirmira, R. G. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283337196 · Cited by 40
Highly cooperative chimeric super-SOX induces naive pluripotency across species
MacCarthy, C. M., Wu, G., Malik, V., Menuchin-Lasowski, Y., Velychko, T., Keshet, G., Fan, R., Bedzhov, I., Church, G. M., Jauch, R., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.11.010 · Cited by 40
Cancer as a reprogramming-like disease: Implications in tumor development and treatment
Castellanos‐Martín, A., Vicente‐Dueñas, C., Campos‐Sánchez, E., Cruz, J. J., García‐Criado, F. J., Cenador, M. B. G., Lazo, P. A., Pérez‐Losada, J., & Sánchez-Garcı́a, I. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.001 · Cited by 39
Inhibition of PTEN Tumor Suppressor Promotes the Generation of Induced Pluripotent Stem Cells
Liao, J., Marumoto, T., Yamaguchi, S., Okano, S., Takeda, N., Sakamoto, C., Kawano, H., Nii, T., Miyamoto, S., Nagai, Y., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.60 · Cited by 40
Foxm1 controls a pro-stemness microRNA network in neural stem cells
Besharat, Z. M., Abballe, L., Cicconardi, F., Bhutkar, A. J., Grassi, L., Pera, L. L., Moretti, M., Chinappi, M., D’Andrea, D., Mastronuzzi, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21876-y · Cited by 39
TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition
Wang, Y., Chen, S., Jiang, Q., Deng, J. V., Cheng, F., Lin, Y., Cheng, L., Ye, Y., Chen, X., Yao, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2684-9 · Cited by 39
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes
Cordani, N., Pozzi, S., Martynova, E., Fanoni, D., Borrelli, S., Alotto, D., Castagnoli, C., Berti, E., Viganò, M., & Mantovani, R. (2010) · Oncogene · doi:10.1038/onc.2010.474 · Cited by 42
Analogy between sphere forming ability and stemness of human hepatoma cells
Tanaka (2010) · Oncology Reports · doi:10.3892/or_00000966 · Cited by 39
Radiation-Induced DNA Damage Cooperates with Heterozygosity of TP53 and PTEN to Generate High-Grade Gliomas
Todorova, P. K., Fletcher-Sananikone, E., Mukherjee, B., Kollipara, R. K., Vemireddy, V., Xie, X., Guida, P. M., Story, M. D., Hatanpaa, K. J., Habib, A. A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0680 · Cited by 40
The emerging functions of the p53-miRNA network in stem cell biology
Lin, C.-P., Choi, Y. J., Hicks, G. G., & He, L. (2012) · Cell Cycle · doi:10.4161/cc.20207 · Cited by 38
Cyclic Stretch Promotes Cellular Reprogramming Process through Cytoskeletal‐Nuclear Mechano‐Coupling and Epigenetic Modification
Park, S., Lee, J., Ahn, K. S., Shim, H. W., Yoon, J., Hyun, J., Lee, J. H., Jang, S., Yoo, K. H., Jang, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202303395 · Cited by 38
Identification and characterization of an oocyte factor required for development of porcine nuclear transfer embryos
Miyamoto, K., Nagai, K., Kitamura, N., Nishikawa, T., Ikegami, H., Binh, N. T., Tsukamoto, S., Matsumoto, M., Tsukiyama, T., Minami, N., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013634108 · Cited by 38
Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
Louwen, F., & Yuan, J. (2013) · Oncotarget · doi:10.18632/oncotarget.1096 · Cited by 38
Lineage Conversion of Murine Extraembryonic Trophoblast Stem Cells to Pluripotent Stem Cells
Kuckenberg, P., Peitz, M., Kubaczka, C., Becker, A., Egert, A., Wardelmann, E., Zimmer, A., Brüstle, O., & Schorle, H. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01047-10 · Cited by 38

Authors: Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
Affiliations: Kyoto University (JP)
RIKEN (JP)
Gladstone Institutes (US)
Corresponding author: Yamanaka, Shinya
ORCID: Takahashi, Kazutoshi
Aoi, Takashi
Kanagawa, Osami
Nakagawa, Masato
Okita, Keisuke
Yamanaka, Shinya
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-08
Volume: 460
Issue: 7259
Pages: 1132-1135
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08235
PMC: PMC2917235
OpenAlex: W2081620485
Cited by: 1,301
References: 23
Citations by year: 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
FWCI: 67.71
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (U01HL100406)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
MeSH terms: Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks